Stock Report

Download full stock data and analysis for free Last Updated: 06-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Finch Therapeutics Group (FNCH) Key Ratios

Stock Card factsheet share-fund-plan-icon

$7.45

up-down-arrow $6.24 (515.70%)

As on 01-Jun-2026 09:30EDT

Market cap

info icon

$15 Mln

Revenue (TTM)

info icon

$6 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 2,149.01 -17.03 --
EBIT -18.30 32.72 73.54 17.85 6.09
Net Profit -24.72 30.45 89.68 20.03 5.89
EPS -24.72 30.49 89.73 24.47 --
Book Value -- -- -60.33 -64.63 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-24Dec-23Dec-22
EBIT-Margin info -21,010.39-10,713.84---31,777.57-10,243.21
Net Margin info ----------
Return on equity info -96.62-68.84-86.83-126.06-76.96
Return on Capital info -56.5399.03-30.88-74.36-64.36
Return on Assets info -51.31-42.34-26.40-68.48-59.05
Debt to Equity (x) info ----3.061.320.55

Profitability

View Detailed Peer Comparison

ROCE

-30.88

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
-30.88
-74.36
-64.36
-97.72
762.47
Peer Median
--
--
--
--
--
ROE

-86.83

--

Profit after tax / Average Net worth * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
-86.83
-126.06
-76.96
-104.89
50.56
Peer Median
--
--
--
--
--
ROA

-26.40

--

Profit after tax / Average Total assets * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
-26.40
-68.48
-59.05
-28.59
-29.19
Peer Median
--
--
--
--
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
-31,777.57
-10,243.21
-323.68
-510.90
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
-69,863.55
-13,315.45
-301.42
-508.46
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
-0.88
-0.95
1.40
-0.24
Peer Median
--
--
--
--
--
EBIT Growth

59.19

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
59.19
61.45
-47.03
-52.11
-86.53
Peer Median
--
--
--
--
--
Net Profit Growth

81.44

--

Year on year growth in profit after tax

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
81.44
34.80
-105.24
-42.32
-89.11
Peer Median
--
--
--
--
--
EPS Growth

0.81

--

Year on year growth in earnings per share

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
0.81
0.35
-1.03
0.75
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

3.06

--

Total debt / Net worth

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
3.06
1.32
0.55
0.03
-0.02
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.25

--

(Short term borrowings / Net worth)

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
0.25
0.15
0.07
0.01
--
Peer Median
--
--
--
--
--
Current Ratio

3.39

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
3.39
6.33
4.84
9.64
9.24
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
--
5.08
10.25
--
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
--
-2.49
-26.07
-372.04
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
--
16.72
2.67
14.19
Peer Median
--
--
--
--
--
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
0.00
0.00
0.09
0.06
Peer Median
--
--
--
--
--
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
245.78
135.32
15.66
138.19
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
-844.16
-417.28
-57.84
0.00
Peer Median
--
--
--
--
--
Payable days

303.33

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
303.33
148.74
160.31
20.27
18.05
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
-747.13
-442.26
-62.45
120.14
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
-0.08
-0.01
-0.28
--
Peer Median
--
--
--
--
--
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
0.25
0.01
0.08
--
Peer Median
--
--
--
--
--
EV/EBITDA

--

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-24
Dec-23
Dec-22
Dec-21
Dec-20
Finch Therapeutics Group (FNCH)
--
-0.33
0.22
1.94
--
Peer Median
--
--
--
--
--
loading...
loading...